| DARE | 8-K | bearish | 7/10 | Dare Bioscience entered into a securities purchase agreement on August 14, 2026, for a ~$6.0M public offering of common | Aug 17, 2026 |
| AMSS | 8-K | bearish | 7/10 | AMASS Brands reported Q2 2026 net revenue of $5.6M, up 2% YoY, but net loss widened to -$7.5M from -$1.3M, driven by a m | Aug 17, 2026 |
| AMCI | 8-K | mixed | 5/10 | AMC Robotics reported Q2 2026 revenue of $937K, down 33% YoY from $1.4M, driven by a strategic shift away from lower-mar | Aug 17, 2026 |
| SCTH | 8-K | neutral | 4/10 | SecureTech Innovations permanently integrated its AI UltraProd subsidiary, abandoning a planned Nasdaq spin-off. The com | Aug 17, 2026 |
| BRBS | 8-K | bullish | 7/10 | Blue Ridge Bankshares (BRBS) has entered into a definitive merger agreement to be acquired by HomeTrust Bancshares (HTB) | Aug 17, 2026 |
| IVF | 8-K | neutral | 4/10 | INVO Fertility reported Q2 2026 revenue of $2.18M (+17% YoY) and net income of $0.9M, swinging from a $(3.6)M loss in Q2 | Aug 17, 2026 |
| HTB | 8-K | bullish | 7/10 | HomeTrust Bancshares (HTB) announced a definitive agreement to acquire Blue Ridge Bankshares (BRBS) in an all-stock tran | Aug 17, 2026 |
| AGIG | 8-K | mixed | 5/10 | Abundia Global Impact Group (AGIG) secured a $10M secured credit facility from its largest shareholder, Bower Family Hol | Aug 17, 2026 |
| DRMA | 8-K | bearish | 7/10 | Dermata Therapeutics entered into a securities purchase agreement for a ~$3.36M private placement, issuing shares, pre-f | Aug 17, 2026 |
| FULC | 8-K | bullish | 8/10 | Fulcrum Therapeutics (FULC) entered into a definitive merger agreement to acquire Slate Medicines in a reverse-merger tr | Aug 17, 2026 |
| SERV | 8-K | bearish | 6/10 | Serve Robotics filed an 8-K disclosing both a new partnership with Grubhub/Wonder and expansion into new markets, but al | Aug 17, 2026 |
| AVXL | 8-K | neutral | 3/10 | Anavex Life Sciences filed an 8-K on August 17, 2026, mailing a letter to stockholders and launching VoteAnavex.com to e | Aug 17, 2026 |
| AMPG | 8-K | neutral | 5/10 | AmpliTech Group issued a business update and financial outlook press release, highlighting a $1 million reduction in the | Aug 17, 2026 |
| ASST | 8-K | neutral | 3/10 | Strive, Inc. filed an 8-K reporting the purchase of 79 bitcoin for approximately $5.0 million during the week of August | Aug 17, 2026 |
| MSTR | 8-K | neutral | 4/10 | Strategy Inc filed an 8-K providing a weekly update on its ATM program, bitcoin holdings, and share repurchases. During | Aug 17, 2026 |
| PNBK | 8-K | neutral | 2/10 | Patriot National Bancorp filed an 8-K on August 17, 2026, to furnish a presentation of certain Q2 2026 financial informa | Aug 17, 2026 |
| BKKT | 8-K | neutral | 3/10 | Bakkt CFO Karen Alexander stepped down effective August 14, 2026, with a transition agreement providing consulting fees | Aug 17, 2026 |
| ISPR | 8-K | neutral | 3/10 | Ispire Technology appointed Steven Przybyla, its Chief Legal Officer and Secretary, as President, a routine structural p | Aug 17, 2026 |
| SCSC | 8-K | neutral | 2/10 | ScanSource announced the retirement of director Peter C. Browning, effective August 12, 2026, reducing the board from ei | Aug 17, 2026 |
| VANI | 8-K | neutral | 3/10 | Vivani Medical filed an 8-K under Item 7.01 to furnish a routine investor slide presentation dated August 17, 2026. The | Aug 17, 2026 |
| LH | 8-K | neutral | 2/10 | Labcorp announced it will host an Investor Day on September 10, 2026, where management will discuss strategy, capital de | Aug 17, 2026 |
| NXGL | 8-K | bearish | 5/10 | NexGel reported Q2 2026 revenue of $3.69 million and a net loss of $2.87 million. The quarter included $795k backlog in | Aug 17, 2026 |
| WYFI | 8-K | bullish | 6/10 | WhiteFiber, Inc. (WYFI) announced a definitive agreement to acquire two industrial properties in Yadkin County, North Ca | Aug 17, 2026 |
| UFI | 8-K | bullish | 7/10 | Unifi (UFI) entered a definitive agreement to sell two non-strategic real estate assets in Yadkin County, NC for $60M in | Aug 17, 2026 |
| QMLS | 8-K | neutral | 4/10 | QumulusAI filed an 8-K providing preliminary Q2 2026 financial estimates ahead of its first earnings call as a public co | Aug 17, 2026 |
| AURX | 8-K | bullish | 5/10 | Nuo Therapeutics reported Q2 2026 revenue of ~$1.77M, up >150% YoY, and a net operating loss of ~$167K, improved by ~$28 | Aug 17, 2026 |
| HIVE | 8-K | bearish | 6/10 | HIVE Digital Technologies reported Q1 FY2027 revenue of $79.1M, up 73.5% YoY, but recorded a GAAP net loss of $142.9M dr | Aug 17, 2026 |
| NRXP | 8-K | bullish | 7/10 | NRx Pharmaceuticals reported Q2 2026 financial results with a net loss of $18.0M for the six months ended June 30, 2026, | Aug 17, 2026 |
| ZURA | 8-K | neutral | 5/10 | Zura Bio filed an 8-K furnishing an updated corporate investor presentation (Exhibit 99.1) as Regulation FD disclosure. | Aug 17, 2026 |
| QBTS | 8-K | neutral | 2/10 | D-Wave Quantum Inc. appointed Kevan P. Krysler as an independent Class I director and Audit Committee member, effective | Aug 17, 2026 |